Liminatus Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIMN and other ETFs, options, and stocks.About LIMN
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
LIMN Key Statistics
Stock Snapshot
As of today, Liminatus Pharma(LIMN) shares are valued at $0.16. The company's market cap stands at 7.49M, with a P/E ratio of -0.43.
On 2026-05-23, Liminatus Pharma(LIMN) stock traded between a low of $0.13 and a high of $0.21. Shares are currently priced at $0.16, which is +23.9% above the low and -20.6% below the high.
The Liminatus Pharma(LIMN)'s current trading volume is 26.45M, compared to an average daily volume of 38.46M.
During the past year, Liminatus Pharma(LIMN) stock moved between $0.13 at its lowest and $33.66 at its peak.
During the past year, Liminatus Pharma(LIMN) stock moved between $0.13 at its lowest and $33.66 at its peak.
LIMN News
Liminatus Pharma (LIMN) announced that the company received a delisting notice from The Nasdaq Stock Market. On May 20, the company received a notice from Nasda...
Liminatus Pharma Inc. (NASDAQ:LIMN) shares are trending on Friday. LIMN shares surged 79.34% to $0.34 after the bell on Thursday. The stock of the biopharmace...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.